FBRX Stock Discussion
Forte Biosciences, Inc. Description
Forte Biosciences, Inc. is a clinical stage, dermatology company developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric (3 years of age and older) patients with atopic dermatitis. There is a significant unmet need for safe and effective therapies particularly for pediatric atopic dermatitis patients.
Industry: Biotechnology
Keywords: Medicine Immunology Monoclonal Antibodies Dermatology Atopic Dermatitis Dermatitis Skin Diseases Type I Hypersensitivity Atopy Sodium Hypochlorite Washes
Recent Comments
- Cos3 on Adding float as advanced filter criteria?
- FriendlyOyster657 on BOOT
- TraderMike on Filtering by News?
- Dr_Duru on Filtering by News?
- TraderMike on Filtering by News?
From the Blog
Popular Now
Featured Articles